RACHEL PARINE: Open Payments
NPI 1043599210 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 102 payments from 15 companies in 2025. Trend: 2023 $828 · 2024 $833 · 2025 $1,847
Food & beverage: $1,727Education: $119
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $441 |
| ABBVIE INC. | 16 | $273 |
| Regeneron Healthcare Solutions, Inc. | 14 | $245 |
| UCB, Inc. | 12 | $186 |
| Organon LLC | 7 | $162 |
| GENZYME CORPORATION | 4 | $120 |
| Incyte Corporation | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| Lilly USA, LLC | 3 | $57 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, OPZELURA, COSENTYX, VTAMA, TALTZ.
Industry payments across WA — which companies pay providers there.
